|
1003
|
Vaxelis
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1004
|
Boostrix
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1005
|
Infanrix
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1006
|
Infanrix-IPV+Hib vaccine
|
Diphtheria
|
Corynebacterium diphtheriae
|
Conjugate
|
GlaxoSmithKline Biologicals S.A
|
Approved
|
Intramuscular
|
NA
|
NCT01309646
|
|
1007
|
Infanrix/Hib
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Approved
|
Intramuscular
|
NA
|
NCT00696423
|
|
1008
|
Infanrix-IPV
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1009
|
Pentacel
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
Sanofi Pasteur Limited and Sanofi Pasteur SA
|
Approved
|
Intramuscular
|
NA
|
NCT00804284
|
|
1010
|
Daptacel
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NCT00258895
|
|
1011
|
Tdvax
|
Diphtheria
|
Corynebacterium diphtheriae
|
Toxoid
|
MassBiologics
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1012
|
Quadracel
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1013
|
Adacel
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1014
|
Pediarix
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1015
|
Kinrix
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
18980534
|
NA
|
|
1016
|
Tenivac
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1017
|
Decavac
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1018
|
DT Generic
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1019
|
DT Polio Adsorbed
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
21441781
|
NA
|
|
1020
|
Infanrix hexa
|
Diphtheria
|
Corynebacterium diphtheriae
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NCT01353703
|
|
1021
|
Hexaxim
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pateur
|
Approved
|
Intramuscular
|
NA
|
NCT02428491
|
|
1022
|
Shan-5
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Healthcare India Private Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1023
|
Actacel
|
Diphtheria
|
Corynebacterium diphtheriae
|
Subunit
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1024
|
Quinvaxem inj.
|
Diphtheria
|
Corynebacterium diphtheriae
|
Subunit
|
Berna Biotech Korea Corp.
|
Approved
|
Intramuscular
|
22889824
|
NA
|
|
1025
|
EasyFive-TT
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Panacea Biotech Ltd.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1026
|
Pentaxim
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur Ltd.
|
Approved
|
Intramuscular
|
21749196
|
NA
|
|
1027
|
Pediacel
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
21999652
|
NA
|
|
1028
|
Tripacel
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1029
|
Tetravac or Tetravac Acellulaire
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1030
|
Boostrix Polio
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1031
|
Td-pur
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Novartis vaccine Diagnostics GmbH & Co. KG.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1032
|
REPEVAX
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1033
|
Adacel Polio
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1034
|
Tripedia
|
Diphtheria
|
Corynebacterium diphtheriae
|
Toxoid
|
Sanofi Pasteur, Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1035
|
Td Polio Adsorbed
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1036
|
Td Adsorbed
|
Diphtheria
|
Corynebacterium diphtheriae
|
Toxoid
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1037
|
Diphtheria and Tetanus Toxoids Adsorbed
|
Diphtheria
|
Corynebacterium diphtheriae
|
Toxoid
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1038
|
Vaxelis
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1039
|
Infanrix
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Inactivated
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1040
|
Infanrix-IPV+Hib
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Conjugate
|
GlaxoSmithKline Biologicals S.A
|
Approved
|
Intramuscular
|
NA
|
NCT01309646
|
|
1041
|
Infanrix/Hib
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
GlaxoSmithKline
|
Approved
|
Intramuscular
|
NA
|
NCT00696423
|
|
1042
|
Infanrix-IPV
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
GlaxoSmithKline
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1043
|
Boostrix
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Inactivated
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1044
|
Pentacel
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Inactivated
|
Sanofi Pasteur Limited and Sanofi Pasteur SA
|
Approved
|
Intramuscular
|
NA
|
NCT00804284
|
|
1045
|
Daptacel
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NCT00258895
|
|
1046
|
Quadracel
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1047
|
Adacel
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1048
|
Pediarix
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1049
|
Kinrix
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
18980534
|
NA
|
|
1050
|
Infanrix hexa
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NCT01353703
|
|
1051
|
Hexaxim
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Pateur
|
Approved
|
Intramuscular
|
NA
|
NCT02428491
|
|
1052
|
Shan-5
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Healthcare India Private Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1053
|
Actacel
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Subunit
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1054
|
Quinvaxem inj.
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Subunit
|
Berna Biotech Korea Corp.
|
Approved
|
Intramuscular
|
22889824
|
NA
|
|
1055
|
EasyFive-TT
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Panacea Biotech Ltd.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1056
|
Pentaxim
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
21749196
|
NA
|
|
1057
|
Pediacel
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
21999652
|
NA
|
|
1058
|
Tripacel
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1059
|
Tetravac or Tetravac Acellulaire
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Pasteur
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1060
|
Boostrix Polio
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1061
|
REPEVAX
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Pasteur
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1062
|
Adacel Polio
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1063
|
Tripedia
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Toxoid
|
Sanofi Pasteur, Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1064
|
Vaxelis
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1065
|
Infanrix
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1066
|
Infanrix-IPV+Hib
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Conjugate
|
GlaxoSmithKline Biologicals S.A
|
Approved
|
Intramuscular
|
NA
|
NCT01309646
|
|
1067
|
Infanrix/Hib
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline
|
Approved
|
Intramuscular
|
NA
|
NCT00696423
|
|
1068
|
Infanrix-IPV
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1069
|
Boostrix
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1070
|
Pentacel
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
Sanofi Pasteur Limited and Sanofi Pasteur SA
|
Approved
|
Intramuscular
|
NA
|
NCT00804284
|
|
1071
|
Daptacel
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NCT00258895
|
|
1072
|
Quadracel
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1073
|
Adacel
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1074
|
Pediarix
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1075
|
Kinrix
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
18980534
|
NA
|
|
1076
|
Tenivac
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1077
|
Decavac
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1078
|
Tdvax
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Toxoid
|
MassBiologics
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1079
|
DT Generic
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1080
|
DT Polio Adsorbed
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
21441781
|
NA
|
|
1081
|
Pentaxim
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
21749196
|
NA
|
|
1082
|
Infanrix hexa
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NCT01353703
|
|
1083
|
Hexaxim
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur
|
Approved
|
Intramuscular
|
NA
|
NCT02428491
|
|
1084
|
Shan-5
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Healthcare India Private Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1085
|
Actacel
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Subunit
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1086
|
Quinvaxem inj.
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Subunit
|
Berna Biotech Korea Corp.
|
Approved
|
Intramuscular
|
22889824
|
NA
|
|
1087
|
EasyFive-TT
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Panacea Biotech Ltd.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1088
|
Pediacel
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
21999652
|
NA
|
|
1089
|
Tripacel
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1090
|
Tetravac or Tetravac Acellulaire
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1091
|
Boostrix Polio
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1092
|
Td-pur
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Novartis vaccine Diagnostics GmbH & Co. KG.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1093
|
REPEVAX
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1094
|
Adacel Polio
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1095
|
Tripedia
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Toxoid
|
Sanofi Pasteur, Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1096
|
Td Polio Adsorbed
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1097
|
Td Adsorbed
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Toxoid
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1098
|
Tetanus Toxoid Adsorbed
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Toxoid
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1099
|
Diphtheria and Tetanus Toxoids Adsorbed
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Toxoid
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1109
|
Plague Vaccine (by Greer Laboratories Inc.)
|
Plague
|
Yersinia pestis
|
Inactivated
|
Greer Laboratories Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1116
|
Typhim Vi
|
Typhoid
|
Salmonella typhi
|
Inactivated
|
Sanofi Pasteur SA
|
Approved
|
Intramuscular
|
24599532
|
NA
|
|
1117
|
Typherix
|
Typhoid
|
Salmonella typhi
|
Inactivated
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
24599532
|
NA
|
|
1118
|
Typbar TCV
|
Typhoid
|
Salmonella typhi
|
Conjugate
|
Bharat Biotech
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1119
|
TYPHIBEV
|
Typhoid
|
Salmonella typhi
|
Conjugate
|
Biological E
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1120
|
PedaTyph
|
Typhoid
|
Salmonella typhi
|
Conjugate
|
BIO-MED Private Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1121
|
Zyvac TCV
|
Typhoid
|
Salmonella typhi
|
Conjugate
|
Cadila Healthcare Ltd
|
Approved
|
Intramuscular
|
32134011, 32725225
|
NA
|
|
1122
|
ViVaxim
|
Typhoid
|
Salmonella typhi
|
Combination
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1123
|
MENVEO
|
Meningococcal disease
|
Neisseria meningitidis
|
Inactivated
|
GSK Vaccines
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1124
|
Menactra
|
Meningococcal disease
|
Neisseria meningitidis
|
Inactivated
|
Sanofi Pasteur Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1125
|
Bexsero
|
Meningococcal disease
|
Neisseria meningitidis
|
Recombinant
|
GSK Vaccines
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1126
|
Bexsero (In UK)
|
Meningococcal disease
|
Neisseria meningitidis
|
Recombinant
|
GSK Vaccines
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1127
|
TRUMENBA
|
Meningococcal disease
|
Neisseria meningitidis
|
Recombinant
|
Pfizer (Wyeth Pharmaceuticals)
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1128
|
MenQuadfi
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
Sanofi Pasteur Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1130
|
MenHibrix
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1131
|
Menitorix
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1132
|
Nimenrix
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
Pfizer
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1133
|
Menjugate
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
GSK Vaccines S.r.l.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1134
|
Meningitec
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
Wyeth Pharmaceuticals
|
Approved
|
Intramuscular
|
12675020
|
NA
|
|
1137
|
NEISVAC-C
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
Pfizer
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1138
|
BIOTHRAX
|
Anthrax
|
Bacillus anthracis
|
Inactivated
|
Emergent BioDefense Operations
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1139
|
Prevnar 20
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
Pfizer
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1140
|
Prevnar 13
|
Pneumococcal
|
Streptococcus pneumoniae
|
Inactivated
|
Pfizer
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1141
|
Prevnar
|
Pneumococcal
|
Streptococcus pneumoniae
|
Inactivated
|
Wyeth Pharmaceuticals Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1142
|
Pneumovax 23
|
Pneumococcal
|
Streptococcus pneumoniae
|
Polysaccharide
|
Merck & Co.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1143
|
VAXNEUVANCE
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
Merck Sharp & Dohme Corp.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1144
|
Synflorix
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1145
|
Pneumosil
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
By collaboration between Serum Institute of India Pvt Ltd and PATH.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1146
|
Vaxelis
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1147
|
Hiberix
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Inactivated
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1148
|
ActHib
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Inactivated
|
Sanofi Pasteur SA
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1149
|
OmniHib
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Conjugate
|
Pasteur Mérieux Serums & Vaccins S. A.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1150
|
MenHibrix
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1151
|
PedvaxHib
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Conjugate
|
Merck and Co. , INC.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1152
|
Pentacel
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Inactivated
|
Sanofi Pasteur Limited and Sanofi Pasteur SA
|
Approved
|
Intramuscular
|
NA
|
NCT00804284
|
|
1153
|
Menitorix
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1154
|
Infanrix hexa
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NCT01353703
|
|
1155
|
Comvax
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
Merck Sharp & Dohme Corp.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1156
|
HibTITER
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Conjugate
|
Lederle-Praxis
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1157
|
ProHIBiT
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Conjugate
|
Connaught
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1158
|
Infanrix-IPV+Hib
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Conjugate
|
GlaxoSmithKline Biologicals S.A
|
Approved
|
Intramuscular
|
NA
|
NCT01309646
|
|
1159
|
Infanrix/Hib
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
GlaxoSmithKline
|
Approved
|
Intramuscular
|
NA
|
NCT00696423
|
|
1160
|
Vaxem Hib
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Conjugate
|
Novartis Vaccines & Diagnostics S.r.l and GlaxoSmithKline
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1161
|
Quinvaxem inj.
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Subunit
|
Berna Biotech Korea Corp.
|
Approved
|
Intramuscular
|
22889824
|
NA
|
|
1162
|
Hexaxim
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
Sanofi Pasteur
|
Approved
|
Intramuscular
|
NA
|
NCT02428491
|
|
1163
|
Shan-5
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
Sanofi Healthcare India Private Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1164
|
Actacel
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Subunit
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1165
|
EasyFive-TT
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
Panacea Biotech Ltd.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1166
|
Pentaxim
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
21749196
|
NA
|
|
1167
|
Pediacel
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
21999652
|
NA
|
|
1169
|
LEP-F1 + GLA-SE
|
Leprosy
|
Mycobacterium leprae
|
Subunit
|
IDRI
|
Clinical - Withdrawn
|
Intramuscular
|
31899025
|
NCT03947437
|
|
1170
|
rF1V
|
Plague
|
Yersinia pestis
|
Recombinant
|
DynPort Vaccine Company LLC, A GDIT Company
|
Clinical - Phase 2
|
Intramuscular
|
23908395
|
NCT01122784
|
|
1172
|
rBV A/B
|
Botulism
|
Clostridium botulinum
|
Recombinant
|
DynPort Vaccine Company LLC, A GDIT Company
|
Clinical - Withdrawn
|
Intramuscular
|
22269871
|
NCT01940315
|
|
1173
|
VLA15
|
Lyme disease (Lyme borreliosis)
|
Borrelia burgdorferi
|
Recombinant
|
Valneva Austria GmbH and Pfizer
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT04801420
|
|
1174
|
mv rOspA LB
|
Lyme disease (Lyme borreliosis)
|
Borrelia burgdorferi
|
Recombinant
|
Baxalta now part of Shire
|
Clinical - Phase 1, Phase 2
|
Intramuscular
|
NA
|
NCT01504347
|
|
1175
|
Bexsero
|
Gonorrhoea
|
Neisseria gonorrhoeae
|
Recombinant
|
University of North Carolina, Chapel Hill
|
Clinical - Phase 4
|
Intramuscular
|
30551148
|
NCT04094883
|
|
1176
|
CTH522
|
Chlamydia
|
Chlamydia trachomatis
|
Recombinant
|
Statens Serum Institut
|
Clinical - Phase 1
|
Intramuscular
|
31416692
|
NCT02787109
|
|
1178
|
SA4AG
|
Methicillin-Resistant Staphylococcus aureus (MRSA)
|
Staphylococcus aureus
|
Polysaccharide
|
Pfizer
|
Clinical - Terminated
|
Intramuscular
|
27916408
|
NCT02388165
|
|
1179
|
SA3Ag
|
Methicillin-Resistant Staphylococcus aureus (MRSA)
|
Staphylococcus aureus
|
Polysaccharide
|
Pfizer
|
Clinical - Phase 1
|
Intramuscular
|
25707693
|
NCT01018641
|
|
1180
|
NDV-3
|
Methicillin-Resistant Staphylococcus aureus (MRSA)
|
Staphylococcus aureus
|
Recombinant
|
NovaDigm Therapeutics, Inc.
|
Clinical - Phase 1
|
Intramuscular
|
25489065
|
NCT01273922
|
|
1182
|
V710
|
Methicillin-Resistant Staphylococcus aureus (MRSA)
|
Staphylococcus aureus
|
Recombinant
|
Merck Sharp & Dohme Corp
|
Clinical - Failed
|
Intramuscular
|
25483690
|
NCT00518687
|
|
1184
|
SP093
|
Salmonellosis
|
Salmonella enteritis
|
Polysaccharide
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT01608815
|
|
1185
|
CTH522 (CHLM-02)
|
Trachoma
|
Chlamydia trachomatis
|
Recombinant
|
Statens Serum Institut
|
Clinical - Phase 1
|
Intramuscular
|
31416692
|
NCT03926728
|
|
1187
|
Sonnei vaccine 1790GAHB
|
Bacillary Dysentery (Shigellosis)
|
Shigella genus
|
Conjugate
|
GlaxoSmithKline
|
Clinical - Phase 1
|
Intramuscular
|
NA
|
NCT03089879
|
|
1189
|
SF2a-TT15
|
Bacillary Dysentery (Shigellosis)
|
Shigella genus
|
Conjugate
|
University of Maryland, Baltimore
|
Clinical - Suspended
|
Intramuscular
|
33186516
|
NCT04078022
|
|
1192
|
O-SPC/rBRU
|
Bacillary Dysentery (Shigellosis)
|
Shigella genus
|
Conjugate
|
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
|
Clinical - Phase 1
|
Intramuscular
|
NA
|
NCT01369927
|
|
1193
|
Flexyn2a
|
Bacillary Dysentery (Shigellosis)
|
Shigella genus
|
Bioconjugate
|
LimmaTech Biologics AG
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT02646371
|
|
1197
|
GVXN SD133
|
Bacillary Dysentery (Shigellosis)
|
Shigella genus
|
Bioconjugate
|
GlycoVaxyn AG
|
Clinical - Phase 1
|
Intramuscular
|
26162850
|
NCT01069471
|
|
1204
|
S.Flexneriza-S.Sonnei Bivalent
|
Bacillary Dysentery (Shigellosis)
|
Shigella genus
|
Conjugate
|
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT04865497
|
|
1207
|
CJCV1
|
Campylobacteriosis
|
Campylobacter genus
|
Conjugate
|
U.S. Army Medical Research and Development Command
|
Clinical - Phase 1
|
Intramuscular
|
30252591
|
NCT02067676
|
|
1208
|
ACE393
|
Campylobacteriosis
|
Campylobacter genus
|
Subunit
|
TD Vaccines A/S
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT00859716
|
|
1209
|
IC43
|
Pseudomonas infection
|
Pseudomonas aeruginosa
|
Recombinant
|
Valneva Austria GmbH
|
Clinical - Phase 2, Phase 3
|
Intramuscular
|
NA
|
NCT01563263
|
|
1210
|
EcoXyn-4V
|
E.coli Infections
|
Escherichia coli
|
Bioconjugate
|
GlycoVaxyn AG
|
Clinical - Phase 1
|
Intramuscular
|
NA
|
NCT02289794
|
|
1217
|
ExPEC9V
|
E.coli Infections
|
Escherichia coli
|
Bioconjugate
|
Janssen Research & Development, LLC
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT04899336
|
|
1222
|
Gynevac
|
Bacterial Vaginosis
|
Gardnerella vaginalis, Lactobacillus, Prevotella, Mobiluncus, Bacteroides, Pepto streptococcus, Fusobacterium, Veillonella, Eubacterium, Mycoplasma hominis, Ureaplasma urealyticum, Streptococcus viridans and Atopobium vaginae.
|
Inactivated
|
Amvac Kft.
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT02173184
|
|
1226
|
GBS Trivalent vaccine
|
Streptococcal Disease, Group B
|
Streptococcus agalactiae (Group B Streptococcus)
|
Conjugate
|
GlaxoSmithKline
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT02270944
|
|
1227
|
GBS Trivalent vaccine
|
Streptococcal Disease, Group B
|
Streptococcus agalactiae (Group B Streptococcus)
|
Conjugate
|
Novartis
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT01446289
|
|
1228
|
J5-OMP vaccine
|
Bacterial Sepsis
|
E.coli, group B Streptococcus, Neisseria meningitidis, Salmonella, Haemophilus influenzae type b, and Listeria monocytogenes.
|
Subunit
|
National Institute of Allergy and Infectious Diseases (NIAID)
|
Clinical - Terminated
|
Intramuscular
|
20593272
|
NCT01164514
|
|
1231
|
ACAM-CDIFF
|
Clostridium Difficile Infection
|
Clostridium difficile
|
Toxoid
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT00772343
|
|
1233
|
IC84
|
Clostridium Difficile Infection
|
Clostridium difficile
|
Recombinant
|
Valneva Austria GmbH
|
Clinical - Phase 1
|
Intramuscular
|
NA
|
NCT01296386
|
|
1234
|
CDIFF Ag
|
Clostridium Difficile Infection
|
Clostridium difficile
|
Recombinant
|
GlaxoSmithKline
|
Clinical - Phase 1
|
Intramuscular
|
NA
|
NCT04026009
|
|
1235
|
VLA84
|
Clostridium Difficile Infection
|
Clostridium difficile
|
Recombinant
|
Valneva Austria GmbH
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT02316470
|
|
1236
|
ID93 + GLA-SE
|
Pulmonary Tuberculosis (TB)
|
Mycobacterium tuberculosis
|
Recombinant
|
Quratis Inc.
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT03806686
|
|
1239
|
GX-70
|
Pulmonary Tuberculosis (TB)
|
Mycobacterium tuberculosis
|
DNA vaccine
|
Yonsei University
|
Clinical - Withdrawn
|
Intramuscular
|
NA
|
NCT03159975
|
|
1241
|
H56
|
Pulmonary Tuberculosis (TB)
|
Mycobacterium tuberculosis
|
Subunit
|
Aeras
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT03512249
|
|
1242
|
AERAS-402
|
Pulmonary Tuberculosis (TB)
|
Mycobacterium tuberculosis
|
Viral vector
|
Aeras
|
Clinical - Phase 2
|
Intramuscular
|
26529238
|
NCT02414828
|
|
1245
|
Zilbrix-Hib
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
18352853
|
NCT00473668
|
|
1246
|
Tritanrix-HepB/ Hiberix
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00473668
|
|
1247
|
Tritanrix-HepB/Hib-MenAC
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00136604
|
|
1248
|
GSK2202083A
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT01171989
|
|
1249
|
HR5I
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Merck Sharp & Dohme Corp.
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT00551629
|
|
1252
|
Tritanrix-HepB/Hib
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00313911
|
|
1254
|
GSK323527A
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00332566
|
|
1255
|
GSK217744
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT01453998
|
|
1256
|
DTaP-IPVvero
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Statens Serum Institut
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00655148
|
|
1257
|
DTaP-IPVmkc
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Statens Serum Institut
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00655148
|
|
1258
|
GSK2036874A
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT01106092
|
|
1260
|
TETRAXIM
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT01031303
|
|
1261
|
SHAN6
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT04429295
|
|
1262
|
BR-TD-1001
|
Diphtheria
|
Corynebacterium diphtheriae
|
Toxoid
|
Boryung Biopharma Co., Ltd.
|
Clinical - Phase 3
|
Intramuscular
|
26091286
|
NCT04618939
|
|
1263
|
Infanrix+Hib
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
18251697
|
NCT01449812
|
|
1264
|
Ditanrix Adult
|
Diphtheria
|
Corynebacterium diphtheriae
|
Toxoid
|
GlaxoSmithKline
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT01294605
|
|
1265
|
GC3111
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Green Cross Corporation
|
Clinical - Phase 2
|
Intramuscular
|
34641798
|
NCT04238975
|
|
1267
|
COVAXIS
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT00304265
|
|
1270
|
diTekiBooster
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Swedish Institute for Infectious Disease Control
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT00870350
|
|
1271
|
SP306 (in Japan)
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT02089347
|
|
1272
|
HEXAVAC
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT01457547
|
|
1274
|
Td-Rix
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT01262924
|
|
1275
|
COVAXIS
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT00304265
|
|
1276
|
diTekiBooster
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Swedish Institute for Infectious Disease Control
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT00870350
|
|
1278
|
TETRAXIM
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT01437423
|
|
1281
|
HEXAVAC
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT01457547
|
|
1282
|
SP306 (in Japan)
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT02089347
|
|
1285
|
DTaP-IPVvero
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Statens Serum Institut
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00655148
|
|
1286
|
DTaP-IPVmkc
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Statens Serum Institut
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00655148
|
|
1287
|
Tritanrix-HepB/Hib-MenAC
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00136604
|
|
1289
|
GSK323527A
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00332566
|
|
1290
|
SHAN6
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT04429295
|
|
1293
|
Tritanrix-HepB/ Hiberix
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00473668
|
|
1294
|
diTekiBooster
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Swedish Institute for Infectious Disease Control
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT00870350
|
|
1295
|
COVAXIS
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Swedish Institute for Infectious Disease Control
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT00870350
|
|
1297
|
TETRAXIM
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT01437423
|
|
1301
|
HEXAVAC
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT01457547
|
|
1302
|
Td-Rix
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT01262924
|
|
1304
|
SP306 (in Japan)
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT02089347
|
|
1306
|
Tritanrix-HepB/Hib-MenAC
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00136604
|
|
1307
|
Tritanrix-HepB/Hib
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00313911
|
|
1308
|
BR-TD-1001
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Toxoid
|
Boryung Biopharma Co., Ltd.
|
Clinical - Phase 3
|
Intramuscular
|
26091286
|
NCT04618939
|
|
1311
|
DTaP-IPVvero
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Statens Serum Institut
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00655148
|
|
1312
|
DTaP-IPVmkc
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Statens Serum Institut
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00655148
|
|
1313
|
Tritanrix-HepB/ Hiberix
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00473668
|
|
1314
|
GSK323527A
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00332566
|
|
1317
|
SHAN6
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT04429295
|
|
1327
|
Vi-TCV
|
Typhoid
|
Salmonella typhi
|
Conjugate
|
University of Maryland, Baltimore
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT03299426
|
|
1328
|
Vi-DT
|
Typhoid
|
Salmonella typhi
|
Conjugate
|
International Vaccine Institute
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT03933098
|
|
1330
|
EuTCV
|
Typhoid
|
Salmonella typhi
|
Conjugate
|
EuBiologics Co.,Ltd
|
Clinical - Phase 2, Phase 3
|
Intramuscular
|
NA
|
NCT04830371
|
|
1336
|
Typhax
|
Typhoid
|
Salmonella typhi
|
Conjugate
|
Matrivax Research and Development Corporation
|
Clinical - Phase 1
|
Intramuscular
|
31905228
|
NCT03926455
|
|
1339
|
Walvax MPV ACYW
|
Meningococcal disease
|
Neisseria meningitidis
|
Polysaccharide
|
Walvax Biotechnology Co., Ltd.
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT04450498
|
|
1340
|
NmCV-5
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
Serum Institute of India Pvt. Ltd.
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT03964012
|
|
1342
|
ProDiax-23
|
Pneumococcal
|
Streptococcus pneumoniae
|
Polysaccharide
|
Korea University Guro Hospital
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT04875858
|
|
1343
|
V114
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
Merck Sharp & Dohme Corp.
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT03547167
|
|
1344
|
NBP606
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
SK Chemicals Co., Ltd.
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT02201030
|
|
1345
|
PCV13i
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
CanSino Biologics Inc.
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT04841369
|
|
1346
|
GSK513026
|
Pneumococcal
|
Streptococcus pneumoniae
|
NA
|
GlaxoSmithKline
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT00307528
|
|
1347
|
LBVE
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
LG Chem
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT03467984
|
|
1348
|
PNCRM9
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
National Institute of Allergy and Infectious Diseases (NIAID)
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT00133549
|
|
1349
|
GEN-004
|
Pneumococcal
|
Streptococcus pneumoniae
|
Subunit
|
Genocea Biosciences, Inc.
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT02116998
|
|
1351
|
Zilbrix-Hib
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
18352853
|
NCT00473668
|
|
1352
|
Tritanrix-HepB/ Hiberix
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00473668
|
|
1353
|
Tritanrix-HepB/Hib-MenAC
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00136604
|
|
1354
|
GSK2202083A
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT01171989
|
|
1355
|
HR5I
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
Merck Sharp & Dohme Corp.
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT00551629
|
|
1356
|
Tritanrix-HepB/Hib
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00313911
|
|
1357
|
GSK323527A
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00332566
|
|
1358
|
SHAN6
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT04429295
|
|
1359
|
Infanrix+Hib
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
18251697
|
NCT01449812
|
|
1360
|
HEXAVAC
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT01457547
|
|
1361
|
Minhai-HIB
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Conjugate
|
Beijing Minhai Biotechnology Co., Ltd
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT02560272
|
|
1363
|
CombAct-HIB
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
31444785
|
NCT00362336
|
|
1364
|
AV7909
|
Anthrax
|
Bacillus anthracis
|
NA
|
Emergent BioSolutions
|
Clinical - Phase 3
|
Intramuscular
|
33199078
|
NCT03877926
|
|
1366
|
rPA-102
|
Anthrax
|
Bacillus anthracis
|
Recombinant
|
VaxGen
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT00100724
|
|
1369
|
Px563L
|
Anthrax
|
Bacillus anthracis
|
Recombinant
|
Pfenex, Inc
|
Clinical - Phase 1
|
Intramuscular
|
34544599
|
NCT02655549
|
|
1370
|
RPA563
|
Anthrax
|
Bacillus anthracis
|
Recombinant
|
Pfenex, Inc
|
Clinical - Phase 1
|
Intramuscular
|
NA
|
NCT02655549
|